Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Douglas E. Onsi$84.2M
Market Cap • 24/04/20242011
(há 13 anos)
2014
(10 years ago)
NASDAQ
Listagem
Cambridge
Sede • Massachusetts44
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
LPTXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.